GENEVA, July 6 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2024/061797) for “TRANSCRIPTOME SIGNATURE ANALYSIS FOR TREATING INFLAMMATION”. With publication no. WO/2026/142696, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12Q 1/6883
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....